What this means
This study is a trial sign-up that is still recruiting people, and no results have been posted yet. It will look at blood samples from patients with a type of lymphoma.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site
The science
- Registered title
- Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
- Trial ID
- NCT06761274 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Hodgkin Lymphoma in Remission
- What is tested
- peripheral blood sampling
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Ages
- 18 Years to no maximum
- Dates
- First posted Jan 7, 2025 · updated Jan 7, 2025
Registry summary
Study design: It is a monocentric and exploratory study, experimental on human tissues in vitro which involves the analysis of peripheral blood in patients with Hodgkin's lymphomas with the following characteristics:
- in complete remission for at least two years after first-line therapy with stage IIb, III or IV at onset (Ann Arbor classification).
- newly diagnosed (stage IIb, III or IV, Ann Arbor Classification).
Sites (1)
- IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna, Italy